Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

9th Circ. Clarifies Kickback Boundaries For Referral Bonuses No Photo Available

Dan McKay

A Ninth Circuit opinion affirming a California man's fraud conviction provides some clarity — and a warning — to the owners of medical... (more story)

Stanford Health Atty Talks AI Ethics In Patient Care No Photo Available

Yeji Jesse Lee

As hospitals embrace artificial intelligence as part of patient care, they're asking an important question: When and how should patients be told?

FCA Draws Heavy Constitutional Fire After $1.6B J&J Verdict No Photo Available

Jeff Overley

Reeling from a record fraud verdict tied to drug promotion practices, Johnson & Johnson is pursuing a sweeping constitutional challeng... (more story)